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Abstract 21 
The main aim of the present study was to estimate size segregated doses from e-cigarette 22 
aerosols as a function of the airway generation number in lung lobes.. After a 2-second puff, 23 
7.7×1010 particles (DTot) with a surface area of 3.6×103 mm2 (STot), and 3.3×1010 particles with 24 
a surface area of 4.2×103 mm2 were deposited in the respiratory system for the electronic and 25 
conventional cigarettes, respectively. Alveolar and tracheobronchial deposited doses were 26 
compared to the ones received by non-smoking individuals in Western countries, showing a 27 
similar order of magnitude. Total regional doses (DR), in head and lobar tracheobronchial and 28 
alveolar regions, ranged from 2.7×109 to 1.3×1010 particles and 1.1×109 to 5.3×1010 particles, 29 
for the electronic and conventional cigarettes, respectively. DR in the right-upper lung lobe 30 
was about twice that found in left-upper lobe and 20% greater in right-lower lobe than the 31 
left-lower lobe.  32 
 33 
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Capsule 38 
Lobar bronchi and right lung lobes represent sites where effects of the aerosol from e-39 
cigarette smoke may be more likely to occur 40 
 41 
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 46 
1. Introduction  47 
 48 
1.1 Background 49 
 50 
 Scientific studies have clearly shown that cigarette smoke is a major cause of premature 51 
death, and a range of adverse health effects, primarily cancer (e.g., lung, oral cavity, 52 
esophagus, larynx, pancreas, bladder, kidney), cardiovascular and chronic obstructive 53 
pulmonary diseases (COPD), myocardial infarction and stroke (Caponnetto et al., 2012; 54 
Crawford et al., 2012; Doll et al., 2004; Fiore et al., 2008; Moolgavkar et al., 2012; WHO, 55 
2008) in human populations. During the cigarette combustion processes, hundreds of toxins 56 
and carcinogens are generated (Baker, 2006; Geiss and Kotzias, 2007). In fact, 9 of the 44 57 
chemical agents classified as “Group 1 carcinogens” by the International Agency for Research 58 
on Cancer (IARC) have been reported to be present in both the vapor and particulate phases 59 
of mainstream (MS) cigarette smoke (the exhaled smoke released after taking a puff on a lit 60 
cigarette) (Smith et al., 2003). Recently, electronic nicotine delivery systems (ENDS), also 61 
known as electronic cigarettes (e-cigarettes), have grown in popularity because they are 62 
considered to be a less harmful and less toxic alternative to tobacco cigarettes, or as a 63 
transitory way to quit smoking (Bullen et al., 2010; Etter, 2010; Etter et al., 2011; Foulds et 64 
al., 2011; McQueen et al., 2011; Polosa et al., 2011; Siegel et al., 2011) and they are also 65 
allowed to be consumed in smoke-free environments. However, to date, their toxicity has not 66 
been scientifically proven compared to tobacco cigarettes (Etter and Bullen, 2011). 67 
E-cigarettes are battery-powered devices made up of an electric atomizer and a replaceable 68 
cartridge containing a water-based liquid (“e-liquid”), composed of propylene glycol, 69 
glycerin, water, flavors and a variable amount of nicotine (Pellegrino et al., 2012; Flouris et 70 
al., 2013; Manigrasso et al., 2015). This e-liquid is heated and vaporized in an atomizer and 71 
then inhaled by the user (vaper). Thus, in e-cigarettes, tobacco combustion is replaced by the 72 
vaporization of e-liquids and it is for this reason that they are claimed to pose a lower risk for 73 
vapers (Cobb et al., 2010; Caponetto et al., 2013). 74 
 75 
1.2 E-cigarette aerosol emission characterization 76 
 77 
 A limited number of scientific studies have aimed to characterize the mainstream aerosol 78 
from e-cigarettes. Schripp et al. (2013) analyzed the emission of fine and ultrafine particles 79 
(UFPs, particle smaller than 100 nm), as well as volatile organic compounds (VOCs) from e-80 
cigarettes, by testing them in a chamber. An increase in both particle and VOC concentrations 81 
was detected. In particular, the e-cigarette-generated aerosol showed a bimodal size 82 
distribution peaking at 60 and 100 nm. Zhang et al. (2013) studied the particle size 83 
distributions of electronic and conventional cigarette aerosols in vitro. The particle number 84 
distribution for e-cigarettes was comparable to that of conventional tobacco in the 100-600 85 
nm range. By applying a lung deposition model to estimate deposition in different respiratory 86 
tracts, they predicted a 7-18 % alveolar delivery, a 9-19 % venous delivery (mostly in the 87 
head) and a 73-80 % loss by exhalation. Fuoco et al. (2014) carried out an experimental 88 
campaign to investigate the effect of different operating parameters, such as type of e-89 
cigarette, flavor, nicotine content and puffing time on particle number concentration and size 90 
distribution in the mainstream aerosol of e-cigarettes. They found e-liquid nicotine content 91 
and puffing time to be the most important parameters influencing particle emission. 92 
 93 
1.3 Aims of the work 94 
 95 
 Data concerning the health effects of e-cigarette vaping are still scarce and far from 96 
being definitive (Flouris and Oikonomou, 2010; Borland and Gray, 2011; Gennimata et al., 97 
2012). Studies have been published on: their short term effects (McCauley et al., 2012; 98 
Vakaòi et al., 2012; Vardavas et al., 2012; Hua et al., 2013; Marini et al., 2014); the effects 99 
exerted by some components of the e-liquid, but not nicotine (Renne, 1992; Moline et al., 100 
2000; Wieslander et al., 2001; Choi et al., 2010; Bahl and et al., 2012); and the potential 101 
health effects of their aerosols (German Cancer Research Center, 2013; Goniewicz et al., 102 
2013). However, in order to correlate aerosol measurements with their health effects, the 103 
particle doses delivered into the respiratory system need to be known. Furthermore, 104 
knowledge of their distribution in the respiratory tree is important because the airway 105 
pathologies caused by deposition of particulate matter have often been reported to occur at 106 
specific sites in the lung, particularly within specific lobes (Winkler-Heil and Hofmann, 107 
2009). From this perspective, Parkash (1977) observed that the right lung is more often the 108 
seat of carcinoma than the left lung, and the upper lobes more often than the lower lobes. The 109 
author speculated that since the right bronchus is wider, shorter and runs almost as a 110 
continuation of the trachea, there is a greater chance of more particles depositing in the right 111 
lung than in the left lung as a whole, which is likely to cause a higher frequency of 112 
malignancies. For this reason, it is important to assess particle deposition in the respiratory 113 
tree, considering the differences between and within the lung lobes. To date, such knowledge 114 
is lacking in relation to e-cigarettes, and therefore, the main aim of this study was to obtain 115 
and compare data for e-cigarettes with the aerosol doses deposited in the respiratory system of 116 
conventional cigarette smokers. For the first time, size segregated dosimetry data for the 117 
aerosol from e-cigarettes have been reported as function of the airway generation number in 118 
lung lobes. The other aim of this work was to make a comparison between the doses received 119 
by vapers and those received by non-smoking individuals frequenting the microenvironments 120 
encountered in typical daily life, where aerosols are originated from a variety of sources. 121 
 122 
 123 
2 Material and Methods 124 
 125 
2.1 Electronic and conventional cigarettes 126 
 127 
 A rechargeable, commercial model e-cigarette, comprising of a tank system and a nicotine 128 
concentration of 14 mg mL-1, was used in the experimental campaign (the flavor is not 129 
important because it was found to have a negligible influence on e-cigarette particle emission 130 
(Fuoco et al. 2014)). With regard to the conventional tobacco cigarettes, cigarettes with a 131 
nicotine concentration equal to 0.8 mg per cigarette were tested, since this represents the 132 
typical nicotine content of commercial cigarettes.  133 
 134 
2.2 Instrumentation and aerosol sampling 135 
 136 
 Cigarette-generated mainstream aerosol measurements were performed in the European 137 
Accredited (EA) Laboratory of Industrial Measurements (LAMI) at the University of Cassino 138 
and Southern Lazio, Italy, where thermo-hygrometric conditions were continuously 139 
monitored, in order to guarantee temperature and relative humidity values equal to 20±1 °C 140 
and 50±10 %, respectively. Measurements of total particle number concentration and particle 141 
size distribution were carried out by a Condensation Particle Counter (CPC 3775, TSI Inc.) 142 
and a Fast Mobility Particle Sizer spectrometer (FMPS 3091, TSI Inc.). The CPC 3775 143 
measures total particle number concentration down to 4 nm in diameter with a 1-s resolution, 144 
and up to a maximum concentration of 107 part. cm-3. It was calibrated before the 145 
experimental campaign by comparison with a TSI 3068B Aerosol Electrometer using NaCl 146 
particles generated by a Submicrometer Aerosol Generator (TSI 3940) (Venditti et al., 2010; 147 
Stabile et al., 2013). The FMPS 3091 measures particle size distribution in the range 5.6 to 148 
560 nm using the electrical mobility technique, with a 1-s time resolution (Johnson et al., 149 
2004). Because of the high particle number concentration in electronic and conventional 150 
cigarette mainstream aerosols, the aerosol was diluted before entering the measurement 151 
section of the instrumental setup. To this end, a thermodilution system (two-step dilution), 152 
made up of a rotating disk thermodiluter, RDTD (model 379020, Matter Engineering AG; 153 
Hueglin et al., 1997) and a thermal conditioner (model 379030, Matter Engineering AG; 154 
Burtscher, 2005) were used. 155 
Mainstream aerosol measurements were performed for puffs of 2-s duration. In particular, 156 
three puff profiles made up of four consecutive puffs with a 30-s inter puff interval were 157 
performed for each test using a time-controlled switch valve. The first puff was considered a 158 
“warm up” puff as it could lead to possible measurement errors when e-cigarettes were tested, 159 
as reported by Ingebrethsen et al. (2012). Before entering the measurement section, the 160 
aerosol passed through the thermodilution system, in order to prevent measurement artifacts 161 
that may have occurred during the sampling process. A scheme of the experimental setup 162 
adopted for mainstream aerosol measurements is reported in Fig. 1 of supplemental material 163 
The thermodilution was performed at a temperature of 37 °C, in order to simulate the 164 
temperature of the human respiratory apparatus. Despite the 5.6-560 nm FMPS measurement 165 
range, only particle distribution data in the range from 14 nm to 523 nm were considered. 166 
This is because (Fuoco et al., 2014) and Ingebrethsen et al. (2012) demonstrated an artifact 167 
when measuring particle distributions of mainstream e-cigarette aerosols in the 5.6-14 nm 168 
diameter range. 169 
 170 
 171 
2.3 Particle dose evaluation 172 
 173 
 Particle deposition in the human respiratory system was evaluated using the Multiple-Path 174 
Particle Dosimetry model (MPPD v2.1, ARA 2009), which calculates the deposition and 175 
clearance of mono and polydisperse aerosols, from ultrafine to coarse particles in the 176 
respiratory system of humans and rats (Anjilvel and Asgharian, 1995; Price et al., 2002). The 177 
model includes single and multiple path methods to calculate air flow and aerosol deposition. 178 
Dosimetry estimates were made by means of the stochastic lung model, because it provides a 179 
more realistic lung geometry than the symmetric one considered in the ICRP model (ICRP, 180 
1994; Manigrasso and Avino, 2012; Manigrasso et al., 2013; Avino et al., 2013). In the 181 
MPPD model, the ten stochastic lungs proposed by Asgharian et al. (Asgharian et al., 2001) 182 
are ordered in size (total number of airways) from the smallest to the largest and the 183 
approximate size percentile of each lung is provided. The 60th percentile human stochastic 184 
lung was considered in this study. The following settings were considered in the application 185 
of the MPPD model: i) a uniformly expanding flow; ii) an upright body orientation; and iii) 186 
oral breathing with a 0.5 inspiratory fraction and no pause fraction. Moreover, the following 187 
parameters were used for a Caucasian adult male who is sitting and awake, based on the ICRP 188 
report (ICRP, 1994): i) a Functional Residual Capacity (FRC) of 3300 mL; ii) an Upper 189 
Respiratory Tract (URT) volume equal to 50 mL; iii) a 12 min-1 breathing frequency; and iv) 190 
an air volume inhaled during a single breath (tidal volume) of 0.75 L. 191 
In regard to the chemical and morphological properties of the e-cigarette-generated aerosols, 192 
the main e-liquid components are propylene glycol and water, and therefore it was assumed 193 
that the particles were spherical and of unitary density. 194 
In order to calculate the overall dose for the particle diameter range measured by the FMPS, 195 
the MPPD model was run separately for the 26 FMPS size channels (from 14 to 523 nm) 196 
considered to be composed of a monodisperse aerosol. 197 
Particle number regional deposition doses in the head (H), trachebronchial (TB) and alveolar 198 
(Al) left-upper (LU), left lower (LL), right-upper (RU), right-middle (RM) and right-lower 199 
(RL) lung lobes were calculated as follows: 200 
i) number dose size distributions 201 
 202 
  (1) 203 
 204 
where R represents the H, TB-LU, TB-LL, TB-RU, TB-RM, TB-RL, Al-LU, Al-LL, Al-RU, 205 
Al-RM, Al-RL regions,  is the deposition fraction at a given R region of particles classified 206 
in the ith size class (calculated by the MPPD model), Ci is the 2-s puff average concentration 207 
of particles in the ith size class and Vp is the puff volume. A 50 cm3 puff volume was used in 208 
this study, as an average of the puff volumes, ranging from 31 to 86 cm3, based on values 209 
reported in the literature for conventional cigarette smoke (Kane et al., 2010; van Dijk et al, 210 
2011; Sahu et al., 2013);  211 
ii) total regional doses:  212 
 213 
  (2) 214 
where 26 is the number of size classes; 215 
iii) functions of particle diameter and of the airway generation number, for each of the 216 
five lung lobes: 217 
 218 
  (3) 219 
where, for each lung lobe,  is the deposition fraction at the Gth airway generation of 220 
particles classified in the ith size class (calculated by the MPPD model); 221 
 222 
iv) total lobar doses per airway generation for each of the five lung lobes: 223 
 224 
 (4) 225 
where the summation is performed over the 26 size classes. Total lobar deposition densities 226 
per airway generation (τRG) were also calculated using the deposition fraction per unit surface 227 
area, instead of , in eq. (3); 228 
 229 
v) total number dose of particles deposited in the respiratory system was calculated as the 230 
sum of total regional doses: 231 
 232 
  (5) 233 
where the summation is calculated over the H, TB-LU, TB-LL, TB-RU, TB-RM, TB-RL, Al-234 
LU, Al-LL, Al-RU, Al-RM and Al-RL regions. Total surface area of deposited particles (STot) 235 
was calculated based on the assumption that all particles were spherical in shape. 236 
 237 
 238 
3 Results and Discussion 239 
 240 
3.1 Mainstream particle number characterization 241 
 242 
 Average particle number concentration in the mainstream aerosol of the e-cigarettes under 243 
investigation (with a nicotine concentration level of 14 mg mL-1) was found to be equal to 244 
5.3 ± 0.58×109 part. cm-3. This value is comparable to the ones measured by Fuoco et al. 245 
(2014) for nicotine-containing e-cigarettes of different flavors. By comparison, the average 246 
particle number concentration in the mainstream aerosol produced by the conventional 247 
tobacco cigarette (with a nicotine concentration of 0.8 mg) was 3.1 ± 0.61×109 part. cm-3. 248 
The differences in total particle number concentration values between the two types of 249 
cigarettes were tested using the Student’s t test, and a p value < 0.01 was regarded as 250 
statistically significant. All the tested data were previously checked for normality using the 251 
Shapiro-Wilk test, in order to fulfill the conditions of the Student’s t test. Statistical analysis 252 
showed that the emissions from conventional cigarettes were statistically lower (p < 0.01) 253 
than from the e-cigarette. 254 
Particle number distributions measured by the FMPS 3091 for both electronic and 255 
conventional cigarettes are reported in Figure 1. Their modes were at about 130 nm and 165 256 
nm, respectively. 257 
 258 
3.2 Tracheobronchial and alveolar deposited particle number and surface area doses 259 
 260 
 Table 1 shows the tracheobronchial and alveolar doses received by a vaper from a 2-s puff, 261 
in terms of deposited particle number and surface area. Alveolar doses of 4.6×1010 particles 262 
and 2.1×103 mm2, as well as tracheobronchial doses of 2.6×1010 particles and 1.2×103 mm2 263 
were estimated for particle number and surface area, respectively. 264 
To put this into perspective, we compared the daily aerosol deposition doses from a single 265 
puff with the daily doses of no-smoking individuals, as well as the doses received while 266 
performing activities that made the most significant contribution to daily doses (sleeping, 267 
cooking and eating, working and commuting). Two different countries were considered: Italy, 268 
in a town (Cassino) characterized by high exposure due to thermal inversion, as well as indoor 269 
cooking activities (Buonanno et al., 2011) and Australia (Brisbane), where lower values were 270 
found (Buonanno et al., 2012; Buonanno et al., 2013). As reported in Table 1, the particle 271 
number deposited doses received by a vaper from a 2-s puff were equivalent to 40% and 31% 272 
of the daily dose received by a non-smoking citizen living in Cassino, for the 273 
tracheobronchial and the alveolar regions, respectively. Such doses were higher than the daily 274 
dose received by a non-smoking citizen living in Brisbane (1.7-fold and 1.4-fold for 275 
tracheobronchial and alveolar regions, respectively). The corresponding particle surface area 276 
doses received by vapers during a 2-s puff were similar to the daily dose received in Cassino 277 
(1.2-fold and 0.8-fold for tracheobronchial and alveolar regions, respectively) and much 278 
higher than those received in Brisbane (5.6-fold and 4.5-fold for tracheobronchial and 279 
alveolar regions, respectively). Once again, this comparison clearly shows the high doses 280 
received by vapers. In Table 1 doses received by conventional cigarette users were also 281 
reported. Tracheobronchial and alveolar doses received during a 2-s puff, in terms of 282 
deposited particle number and surface area, respectively, were estimated equal to 283 
1.1×1010 particles/1.5×103 mm2 (TB) and 1.9×1010 particles/2.3×103 mm2 (Al). Therefore, 284 
particle number doses were significantly lower than those due to e-cigarette use, whereas 285 
particle surface area doses were slightly higher: this was due to the emission of i) lower 286 
number of particles and ii) larger particles’ mode when conventional cigarettes are used 287 
(Figure 1). 288 
 289 
3.3 Size resolved lobar doses 290 
 291 
 After a 2-s e-cigarette puff, 7.7×1010 particles (DTot) with a surface area of 3.6×103 mm2 292 
(STot) and 3.3×1010 particles with a surface area of 4.2×109 mm2 were deposited in the 293 
respiratory system, for electronic and conventional cigarettes, respectively. The number dose 294 
size distributions, DRi, (Figure 2) were uninomodal for head TB and Al lobar regions, with a 295 
mode at 124 nm (e-cigarette) and 165 nm (conventional cigarette), as exhibited by the 296 
relevant aerosol number size distributions. For the tracheobronchial region, at the modal 297 
diameter, DRi ranged from 3.1×108 (TB-RM) to 7.2×108 (TB-RL) particles and from 1.8×108 298 
(TB-RM) to 4.4×108 (TB-RU), for e-cigarettes and conventional cigarettes, respectively. For 299 
the alveolar region, DRi ranged from 6.8×108 (Al-RM) to 1.6×109 (Al-RL) particles and from 300 
3.8×108 (Al-RM) to 9.0×108 (Al-RL) particles, for e-cigarettes and conventional cigarettes, 301 
respectively. 302 
Figure 3 shows the total regional doses, DR, deposited in the head, TB and Al lung lobes. DR 303 
in the head was 4.9×109 particles for the e-cigarette and 2.8×109 particles for the conventional 304 
one. In the lung lobes, the lowest DR was deposited in the RM-TB region (2.7×109 particles, 305 
for the e-cigarette and 1.1×109 particles for the conventional cigarette) and the highest was in 306 
Al-RL region (1.3×1010 particles for the e-cigarette and 5.3×109 particles for the conventional 307 
cigarette). Total regional doses were higher for right lobes than for the left ones. In the TB 308 
region of the RU lobe, 116% (e-cigarette) and 123% (conventional cigarette) more particles 309 
were deposited than in the LU, and about 20% (e-cigarette) and 17%, (conventional cigarette) 310 
more were deposited in the RL than in the LL lobe. 311 
In the alveolar region, about 99% (e-cigarette) and 98% (conventional cigarette) more 312 
particles were deposited in the RU than in the LU lobe, and about 28% (both kinds of 313 
cigarettes) more were deposited in the RL than in the LL lobe. DR was higher in lower than in 314 
the upper lobes. In the TB region, about 85% (e-cigarette) and 87% (conventional cigarette) 315 
more particles were deposited in the LL than in the LU lobe. The dose received by the RL and 316 
RU lobe were similar: 3% higher and 1% lower for the RL lobe, for the electronic and 317 
conventional cigarettes respectively. In the alveolar region, DR was about 79% (both kinds of 318 
cigarettes) higher for the LL than for the LU lobe, and about 16 % (e-cigarette) and 15% 319 
(conventional cigarette) higher for the RL than for the RU lobe.  320 
Figure 4 shows the total lobar doses per airway generation, DRG, (a, c) and the total deposition 321 
densities, τRG, (b, d) per airway generation as functions of airway generation number, for each 322 
of the five lung lobes. Maximum DRG ranged from 7.9×108 (e-cigarette) and 3.2×108 particles 323 
(conventional cigarette) for the RM lobe, to 2.2×109 (e-cigarette) and 8.7×108 particles 324 
(conventional cigarette) for the RL lobe. Maximum DRG were deposited in the 19th (e-325 
cigarette) and 20th (conventional cigarette) airway generations in the LU lobe and in the 21st 326 
generation in the LL and RU lobes and the 22nd generation in RM and RL lobes, for both 327 
kinds of cigarettes. Total lobar deposition densities per airway generation (τRG) were also 328 
estimated (Figure 4 b, d), since the number of deposited particles per unit airway surface area 329 
(deposition density) for inhaled particles, such as irritants which affect tissues on contact, 330 
represents a more relevant parameter, rather than particle number (McClellan and Henderson, 331 
1995). τRG was highest in the upper bronchial generations, with maximum values of 6.7×107 332 
and 3.8×107 particles cm-2 at the third airway generation (i.e. at lobar bronchi), for e-cigarettes 333 
and conventional cigarettes, respectively. τRG decreased further down the peripheral 334 
bronchiolar airways, due to the increasing airway surface area. 335 
The contour plots in Figures 5 and 6 show the dose number size distributions (DiG) as a 336 
function of airway generation number and particle diameter in each of the five lung lobes, for 337 
both kinds of cigarettes, after a single 2-s puff. The position of peak values were determined 338 
by the modes of the size number distribution of the cigarette aerosols and by airway 339 
generation numbers at which particle with modal diameter most efficiently deposit. It can be 340 
seen that the DiR peaks were located at 124 nm (e-cigarette) and 165 (conventional cigarette) 341 
size class particles (the mode of the aerosol size-number distributions) at the 20th airway 342 
generation for the LU lobe, at the 21st for the LL and RU lobes, and at the 22nd for the RM 343 
and RL lobes, for both kinds of cigarettes. DiR peaks ranged from 9.5×107 (e-cigarette) and 344 
5.4×107 (conventional cigarette) in the RM lobe, to 2.6×108 (e-cigarette) and 1.5×108 particles 345 
in the RL lobe. 346 
 347 
 348 
4. Conclusions 349 
 350 
 After a single 2-s puff, 7.7×1010 particles (DTot ) are deposited, which is more than double 351 
the dose compared to conventional cigarettes. In the tracheobronchial and alveolar regions, a 352 
single puff delivers total regional doses (DR) that represent 40% and 30% of the daily dose of 353 
a no-smoking Italian individual and 170% and 140% of the daily dose of a no-smoking 354 
Australian subject, respectively. 355 
Higher total lobar doses per airway generation ( ) were deposited in the alveolar region, 356 
whereas higher total lobar deposition densities per airway generation ( ) occurred at the 357 
lobar bronchi. Total regional doses, DR, were not uniformly distributed in the lung lobes, with 358 
twice as many particles deposited in the RU than in the LU lobes and about 20% more in the 359 
RL than in the LL lobes, both for the tracheobronchial and the alveolar regions. Thus, the 360 
lobar bronchi and right lung lobes represent sites where effects of the aerosol from e-cigarette 361 
smoke may be more likely to occur. Further studies are needed on the chemical composition 362 
of e-cigarette aerosols, in order to ascertain the doses of noxious substances delivered by the 363 
aerosol doses estimated in this study. 364 
 365 
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 540 
Table 1. Alveolar (Al) and Tracheobronchial (TB) particle doses in terms of number (N) and 541 
surface area (S) received by e-cigarettes vapers and conventional cigarette smokers: 542 
comparison with doses experienced by Italian and Australian subjects on a daily-543 
basis and in the most commonly frequented microenvironments. The ratios (TB-N 544 
Ratio, TB-S Ratio, Al-N Ratio, Al-S Ratio) between the doses received by vapers 545 
after 2-s puff and the ones of Italian and Australian subjects are also reported. 546 
Cigarette TB-N (particles) 
 
TB-S 
(mm2) 
 
Al-N 
(particles) 
 
Al-S 
(mm2) 
 E-cig. (2-s) 2.6×1010 1.2×103 4.6×1010 2.1×103 
Conv. cig. (2-s) 1.1×1010 1.5×103 1.9×1010 2.3×103 
Italian case TB-N (particles) 
TB-N 
Ratio 
TB-S 
(mm2) 
TB-S 
Ratio 
Al-N 
(particles) 
Al-N 
Ratio 
Al-S 
(mm2) 
Al-S 
Ratio 
Daily 6.5×1010 0.4 1.0×103 1.2 1.5×1011 0.3 2.5×103 0.8 
Sleeping 3.6×109 7.2 2.3×101 52.0 5.8×109 7.9 7.3×101 28.7 
Cooking and eating 1.9×1010 1.4 4.0×102 3.0 4.5×1010 1.0 7.7×102 2.7 
Working 2.3×1010 1.1 2.8×102 4.4 5.8×1010 0.8 4.3×102 4.9 
Commuting 5.0×109 5.2 2.4×101 50.9 8.4×109 5.5 8.8×101 24.0 
Australian case TB-N (particles) 
TB-N 
Ratio 
TB-S 
(mm2) 
TB-S 
Ratio 
Al-N 
(particles) 
Al-N 
Ratio 
Al-S 
(mm2) 
Al-S 
Ratio 
Daily 1.5×1010 1.7 2.1×102 5.6 3.2×1010 1.4 4.7×102 4.5 
Sleeping 1.8×109 14.7 3.2×101 37.9 3.3×109 14.1 5.6×101 37.2 
Cooking and eating 3.4×109 7.6 8.8×101 13.6 7.1×109 6.5 1.9×102 10.8 
Working 2.4×109 11.0 2.1×101 58.7 5.9×109 7.9 5.4×101 38.7 
Commuting 8.3×108 31.5 7.6×100 158.6 1.7×109 27.3 1.7×101 125.5 
 547 
548 
 549 
 550 
Figure captions 551 
 552 
Figure 1. Comparison between particle number size-distributions of the mainstream aerosol 553 
generated by e-cigarettes and conventional tobacco cigarettes measured through the 554 
FMPS 3091. 555 
 556 
Figure 2. Particle dose number size-distribution in different lung regions: a) head (H) and 557 
tracheobronchial (TB) regions for e-cigarette; b) alveolar (Al) region for e-558 
cigarette; c) head (H) and tracheobronchial (TB) regions for conventional cigarette; 559 
and d) alveolar (Al) region for e conventional cigarette. 560 
 561 
Figure 3. Total regional lobar doses (DR) in the: (a) head (H) and tracheobronchial (TB); and 562 
(b) alveolar (Al) regions. 563 
 564 
Figure 4. Total lobar doses per airway generation ( ) and total lobar deposition densities 565 
per airway generation ( ) for electronic and conventional cigarettes: a)  for e-566 
cigarette; b)  for electronic cigarettes; c)  for conventional cigarettes; and d) 567 
 for conventional cigarettes. 568 
 569 
Figure 5. Dose number size distributions as functions of airway generation number in RL (a, 570 
d), RM (b, e) and RU (c, f) lung lobes for an electronic (left) and a conventional 571 
(right) cigarette smoker. 572 
 573 
Figure 6. Dose number size distributions as functions of airway generation number in LL (a, 574 
c) and LU (b, d) lung lobes for an electronic (left) and a conventional (right) 575 
cigarette smoker. 576 
 577 
578 
 579 
 580 
Caption of Supplementary Material 581 
 582 
Figure 1. Scheme of the experimental setup adopted for mainstream aerosol measurements. 583 
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